I
Indapta Therapeutics
1 follower
Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.
Org chart
Mark W. Frohlich
Collapse
Robert Sikorski
Acting Chief Medical Officer
Austin Bigley
VP, Research
Stefanie Mandl-Cashman
Acting Chief Scientific Officer
Board & advisors
Ronald Martell
Executive Chairman & Co-Founder
Nina Shah
Advisor
Sungjin Kim
Advisor
John Sunwoo
Advisor
Todd A. Fehniger
Advisor
Vaughn Smider
Advisor
Laura Stoppel
Director
Fabio Pucci
Director
Ran Nussbaum
Director